DIA
Drug Information Association Logo
« Back to Listing

Risk Sharing or Risk Transfer? Striking the Perfect Balance in Strategic Partnerships

Track:
Innovative Partnering Models and Outsourcing Strategies

Day & Time:
June 16, 11:00AM - 12:30PM (Pacific Standard Time)

Session Number:
127

Room Number:
3

Level:
Intermediate

Type:
Forum

Title:
Risk Sharing or Risk Transfer? Striking the Perfect Balance in Strategic Partnerships

Chair(s):
Andrew Townshend
Vice President, Alliance Development
INC Research, United States

Description:
Sponsors continue to pursue partnerships that transfer accountability to their CRO partners based on performance, while CROs seek a better balance between risk and reward. This forum explores risk-sharing arrangements, related benefits, and drawbacks.

Learning Objective(s):
Assess when it makes sense to evolve beyond a tactical relationship; Evaluate the benefits and drawbacks of different risk-sharing arrangements; Apply strategies to ensure more successful partnerships.

Presentation(s) & Speaker(s):
Panelist
Mark L. Lacy
CEO
Benchmark Research, United States

Panelist
Mark A. Sanders, MBA
Senior Director, Clinical Development and Medical Sourcing Lead
Pfizer Inc, United States

Panelist
Linda G Strause, PhD
Principal and Founder
Strategic Clinical Consultants, United States